Back to overview

Meet Neumirna at Conferences and Events in 2026

Find out where you can connect with our team this year
Written by: The Neumirna Team
March 30, 2026

Throughout the year, we will be present at leading scientific conferences in our therapeutic areas, as well as key investor and partnering events across the biotech industry.

These events will be our primary touchpoints for sharing updates on our pipeline, scientific progress, and microRNA targeting approach.

We look forward to connecting with partners, investors, and the broader scientific community.

Investor & Partnering Conferences

BioEquity Europe 2026 – Prague, Czech Republic
May 4–6, 2026

BIO International Convention – San Diego, USA
‍
June 22–25, 2026

RNA Leaders, Boston, USA
September 23-25, 2026

26th Annual Biotech in Europe Forum – Basel, Switzerland
October 7-8, 2026

BIO Europe 2026 – Cologne, Germany
November 9–11, 2026

Jefferies Global Healthcare Conference – London, UK
November 16–19, 2026

London Life Sciences Week – London, UK
November 15-20, 2026.

Scientific & Clinical

MJFF Q1 Therapeutic Stewardship Meeting – New York, USA
March 11, 2026

AD/PD 2026 – Copenhagen, Denmark
March 17–21, 2026

2026 Research Roundtable for Epilepsy – Washington DC, USA
April 30–May 1, 2026

German Society for Epileptology (DGfE) Annual Meeting – Würzburg, Germany
June 10–13, 2026

Epilepsy Pipeline Conference 2026 – Leesburg, VA, USA
June 18–19, 2026

‍16th European Epilepsy Congress – Athens, Greece‍
September 5-9, 2026

RNA Horizons Conference 2026 – Munich, Germany
September 16-18, 2026

7th Nordic Nucleic Acid Based Medicine Industry Network – Copenhagen, Denmark
‍
September 17, 2026

ISFTD 5th International Conference on Frontotemporal Dementias – Philadelphia, USA
October 8-11, 2026

The 22nd Annual Meeting of the Oligonucleotide Therapeutics Society (OTS) – Denver, USA
October 11-14, 2026

The Michael J. Fox Foundation's annual Parkinson's Disease Therapeutics Conference (PDTC) – New York City, USA
October 14 - 15, 2026

TIDES Oligonucleotide and Peptide Therapeutics – Amsterdam, Netherlands
November 3-5, 2026

Novel CNS Biomarkers Summit – London, UK
December 1, 2026

American Epilepsy Society 2026 – Denver, Colorado, USA
December 4-8, 2026

Funding
Publication
27.3.2026
Meet Neumirna at Conferences and Events in 2026
Find out where you can connect with our team this year
Read full article
Development
Publication
12.1.2026
Neumirna at AES: new data on NMT.001
At the American Epilepsy Society Annual Meeting, Neumirna presented two posters highlighting the potential of its RNA-based approach for drug-resistant epilepsy.
Read full article
Funding
Awards
12.6.2025
Neumirna Receives 2024 CURE Epilepsy Catalyst Award
$250,000 in funding to support biomarker research and development of RNA therapy for drug-resistant epilepsy
Read full article
Back to overview

Meet Neumirna at Conferences and Events in 2026

Find out where you can connect with our team this year
Written by: The Neumirna Team
March 30, 2026

Throughout the year, we will be present at leading scientific conferences in our therapeutic areas, as well as key investor and partnering events across the biotech industry.

These events will be our primary touchpoints for sharing updates on our pipeline, scientific progress, and microRNA targeting approach.

We look forward to connecting with partners, investors, and the broader scientific community.

Investor & Partnering Conferences

BioEquity Europe 2026 – Prague, Czech Republic
May 4–6, 2026

BIO International Convention – San Diego, USA
‍
June 22–25, 2026

RNA Leaders, Boston, USA
September 23-25, 2026

26th Annual Biotech in Europe Forum – Basel, Switzerland
October 7-8, 2026

BIO Europe 2026 – Cologne, Germany
November 9–11, 2026

Jefferies Global Healthcare Conference – London, UK
November 16–19, 2026

London Life Sciences Week – London, UK
November 15-20, 2026.

Scientific & Clinical

MJFF Q1 Therapeutic Stewardship Meeting – New York, USA
March 11, 2026

AD/PD 2026 – Copenhagen, Denmark
March 17–21, 2026

2026 Research Roundtable for Epilepsy – Washington DC, USA
April 30–May 1, 2026

German Society for Epileptology (DGfE) Annual Meeting – Würzburg, Germany
June 10–13, 2026

Epilepsy Pipeline Conference 2026 – Leesburg, VA, USA
June 18–19, 2026

‍16th European Epilepsy Congress – Athens, Greece‍
September 5-9, 2026

RNA Horizons Conference 2026 – Munich, Germany
September 16-18, 2026

7th Nordic Nucleic Acid Based Medicine Industry Network – Copenhagen, Denmark
‍
September 17, 2026

ISFTD 5th International Conference on Frontotemporal Dementias – Philadelphia, USA
October 8-11, 2026

The 22nd Annual Meeting of the Oligonucleotide Therapeutics Society (OTS) – Denver, USA
October 11-14, 2026

The Michael J. Fox Foundation's annual Parkinson's Disease Therapeutics Conference (PDTC) – New York City, USA
October 14 - 15, 2026

TIDES Oligonucleotide and Peptide Therapeutics – Amsterdam, Netherlands
November 3-5, 2026

Novel CNS Biomarkers Summit – London, UK
December 1, 2026

American Epilepsy Society 2026 – Denver, Colorado, USA
December 4-8, 2026

Funding
Publication
27.3.2026
Meet Neumirna at Conferences and Events in 2026
Find out where you can connect with our team this year
Read full article
Development
Publication
12.1.2026
Neumirna at AES: new data on NMT.001
At the American Epilepsy Society Annual Meeting, Neumirna presented two posters highlighting the potential of its RNA-based approach for drug-resistant epilepsy.
Read full article
Funding
Awards
12.6.2025
Neumirna Receives 2024 CURE Epilepsy Catalyst Award
$250,000 in funding to support biomarker research and development of RNA therapy for drug-resistant epilepsy
Read full article